Cite
HARVARD Citation
Damy, T. et al. (2021). Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study. European journal of heart failure. pp. 277-285. [Online].